Claus H. Schröder

2.5k total citations
57 papers, 2.1k citations indexed

About

Claus H. Schröder is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Claus H. Schröder has authored 57 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 19 papers in Molecular Biology and 18 papers in Hepatology. Recurrent topics in Claus H. Schröder's work include Hepatitis B Virus Studies (26 papers), Herpesvirus Infections and Treatments (15 papers) and Hepatitis C virus research (13 papers). Claus H. Schröder is often cited by papers focused on Hepatitis B Virus Studies (26 papers), Herpesvirus Infections and Treatments (15 papers) and Hepatitis C virus research (13 papers). Claus H. Schröder collaborates with scholars based in Germany, China and United States. Claus H. Schröder's co-authors include Hanswalter Zentgraf, H. C. Kaerner, George G. Skouteris, C.–Thomas Bock, Peter Schranz, Qin Su, Hans Jörg Hacker, G. Kümel, Peter Bannasch and Gerd Otto and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Claus H. Schröder

57 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claus H. Schröder Germany 25 1.5k 909 595 251 247 57 2.1k
Stephen Griffin United Kingdom 29 1.3k 0.9× 1.2k 1.3× 786 1.3× 504 2.0× 281 1.1× 54 2.6k
Daniel J. Tenney United States 32 3.8k 2.5× 2.6k 2.9× 448 0.8× 621 2.5× 356 1.4× 63 4.2k
Julie Lucifora France 27 1.8k 1.2× 1.4k 1.5× 434 0.7× 388 1.5× 491 2.0× 63 2.3k
John McLauchlan United Kingdom 31 1.8k 1.2× 1.5k 1.6× 1.4k 2.4× 295 1.2× 487 2.0× 79 3.8k
Timothy L. Tellinghuisen United States 21 2.7k 1.7× 3.3k 3.6× 1.1k 1.8× 687 2.7× 360 1.5× 29 4.5k
Sharookh B. Kapadia United States 19 2.1k 1.4× 2.2k 2.4× 918 1.5× 302 1.2× 541 2.2× 27 3.7k
Laurence Cocquerel France 29 1.5k 1.0× 2.3k 2.6× 664 1.1× 450 1.8× 238 1.0× 57 3.1k
Donald R. O’Boyle United States 25 1.8k 1.2× 1.4k 1.6× 341 0.6× 722 2.9× 158 0.6× 37 2.4k
J H Ou United States 29 2.5k 1.6× 1.8k 2.0× 673 1.1× 525 2.1× 350 1.4× 38 3.2k
Stephanie Kallis Germany 20 2.1k 1.4× 2.5k 2.8× 833 1.4× 445 1.8× 293 1.2× 22 3.5k

Countries citing papers authored by Claus H. Schröder

Since Specialization
Citations

This map shows the geographic impact of Claus H. Schröder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus H. Schröder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus H. Schröder more than expected).

Fields of papers citing papers by Claus H. Schröder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus H. Schröder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus H. Schröder. The network helps show where Claus H. Schröder may publish in the future.

Co-authorship network of co-authors of Claus H. Schröder

This figure shows the co-authorship network connecting the top 25 collaborators of Claus H. Schröder. A scholar is included among the top collaborators of Claus H. Schröder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus H. Schröder. Claus H. Schröder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wei, Shaojun Zhu, Yan Zhang, et al.. (2008). Hepatitis B Virus X‐DNA. Annals of the New York Academy of Sciences. 1137(1). 264–272. 1 indexed citations
2.
Zhang, Wei, et al.. (2003). Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy. Journal of Medical Virology. 71(1). 24–30. 29 indexed citations
3.
Deres, Karl, Claus H. Schröder, Siegfried Goldmann, et al.. (2003). Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids. Science. 299(5608). 893–896. 418 indexed citations
4.
Bannasch, Peter & Claus H. Schröder. (2002). Pathogenesis of primary liver tumours. 3 indexed citations
5.
Butz, Karin, Claudia Denk, B.A. Fitscher, et al.. (2001). Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity. Oncogene. 20(45). 6579–6586. 65 indexed citations
6.
Su, Qin, Claus H. Schröder, Gerd Otto, & Peter Bannasch. (2000). Overexpression of p53 protein is not directly related to hepatitis B x protein expression and is associated with neoplastic progression in hepatocellular carcinomas rather than hepatic preneoplasia. Mutation Research/Reviews in Mutation Research. 462(2-3). 365–380. 26 indexed citations
7.
Beerheide, Walter, et al.. (1999). Truncated Hepatitis B Virus RNA in Human Hepatocellular Carcinoma: Its Representation in Patients with Advancing Age. Intervirology. 42(4). 228–237. 25 indexed citations
8.
Su, Qin, Claus H. Schröder, Walter Hofmann, et al.. (1998). Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology. 27(4). 1109–1120. 179 indexed citations
9.
Skouteris, George G. & Claus H. Schröder. (1996). c-MycandMaxInteractions in Quiescent and Mitogen-Stimulated Primary Hepatocytes. Experimental Cell Research. 225(2). 237–244. 5 indexed citations
10.
Berns, Hartmut, et al.. (1992). Mutations on Free and Integrated Hepatitis B Virus DNA in a Hepatocellular Carcinoma: Footprints of Homologous Recombination. Oncology. 49(5). 386–395. 35 indexed citations
11.
Liang, Xiao‐Huan, Ivan Lončarević, Zhao–You Tang, et al.. (1991). Resection of hepatocellular carcinoma: Oligocentric origin of recurrent and multinodular tumours. Journal of Gastroenterology and Hepatology. 6(1). 77–80. 14 indexed citations
12.
Schranz, Peter, Hanswalter Zentgraf, Ivan Lončarević, Michael Niepmann, & Claus H. Schröder. (1990). Defective replication units of hepatitis B virus. Journal of Virology. 64(4). 1851–1854. 13 indexed citations
13.
Lončarević, Ivan, Peter Schranz, Hanswalter Zentgraf, et al.. (1990). Replication of hepatitis B virus in a hepatocellular carcinoma. Virology. 174(1). 158–168. 29 indexed citations
14.
Schranz, Peter, et al.. (1989). A viable HSV-1 mutant deleted in two nonessential major glycoproteins. Virology. 170(1). 273–276. 5 indexed citations
15.
Kümel, G., Claus H. Schröder, & H. C. Kaerner. (1986). Neurovirulence and latency in inbred mice of two HSV-1 intrastrain variants of divergent pathogenicity. Medical Microbiology and Immunology. 174(6). 313–324. 2 indexed citations
17.
Kümel, G., et al.. (1982). Viral interference of HSV-1: Properties of the intracellular viral progeny DNA. Virology. 120(1). 205–214. 3 indexed citations
18.
Schröder, Claus H., et al.. (1982). Low Infectivity of HSV-1 DNA Caused by Defective-interfering Genomes. Journal of General Virology. 63(2). 307–314. 10 indexed citations
19.
Kaerner, H. C., et al.. (1981). Amplification of a short nucleotide sequence in the repeat units of defective herpes simplex virus type 1 Angelotti DNA. Journal of Virology. 39(1). 75–81. 26 indexed citations
20.
Schröder, Claus H., et al.. (1978). Excess of Interfering over Infectious Particles in Herpes Simplex Virus Passaged at High m.o.i. and their Effect on Single-cell Survival. Journal of General Virology. 41(3). 493–501. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026